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Introduction
Computerised databases of primary care clinical rec-
ords are widely used for epidemiological research,
particulary in studies of disease prevalence and inci-
dence, studies of health services and in pharmacoepi-
demiological research.1 In Catalonia, the Information
System for the Development of Research in Primary
Care (SIDIAP) was created in 2010 by the Catalan
Institute of Health (ICS) and the Jordi Gol Primary
Care Research Institute (IDIAP Jordi Gol). Its main
aim is to promote the development of research based
on high-quality validated data from primary care
electronic medical records.2 SIDIAP contains anony-
mised longitudinal patient information including
sociodemographic characteristics, morbidity (Inter-
national Classiﬁcation of Diseases; ICD-10), clinical
and lifestyle variables, laboratory tests and treatments
(drug prescriptions, drugs purchased at the commu-
nity pharmacy and hospital discharge information).
However, data from electronic primary care records
are collected for clinical practice rather than research
purposes and so investigators need to consider not
only the validity and completeness of the data con-
tained therein, but also the extent to which this data
can be generalised to the population as a whole. There
aremany similar research databases in Europe, such as
the General Practice Research Database (GPRD),3 the
MediPlus database4 and the Doctors Independent
Network database (DIN),5 and in the USA,6 that are
widely used for observational studies. In the majority
of these databases, data are entered on a voluntary
basis by general practitioners (GPs), who are required
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Objective The purpose of this study is to create and
validate a scoring system (Registry Quality Score,
RQS) that will enable all primary care practices
(PCPs) to be selected as providers of research-
usable data based on the completeness of their
registers.
Methods Diseases that were likely to be represen-
tative of common diagnoses seen in primary care
were selected for RQS calculations. The observed/
expected cases ratio was calculated for each disease.
Once we had obtained an estimated value for this
ratio for each of the selected conditions we added
up the ratios calculated for each condition to obtain
a ﬁnal RQS. Rate comparisons between observed
and published prevalences of diseases not included
in the RQS calculations (atrial ﬁbrillation, diabetes,
obesity, schizophrenia, stroke, urinary incontinence
and Crohn’s disease) were used to set the RQS cut-
oﬀwhich will enable researchers to select PCPs with
research-usable data.
Results Apart from Crohn’s disease, all preva-
lences were the same as those published from the
RQS fourth quintile (60th percentile) onwards. This
RQS cut-oﬀ provided a total population of 1 936 443
(39.6% of the total SIDIAP population).
Conclusions SIDIAP is highly representative of the
population of Catalonia in terms of geographical,
age and sex distributions. We report the usefulness
of rate comparison as a valid method to establish
research-usable data within primary care electronic
medical records.
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What was already known
. Primary care databases, containing validated data coded in electronic medical records provide a powerful
source of data for epidemiological research.
. Several methods have been used to assess the completeness and accuracy of registers in such data.
What this study added to our knowledge
. We report, for the ﬁrst time, the usefulness of rate comparison as a validmethod for establishing research-
usable data within primary care electronic medical records.
. We also introduce SIDIAP to the scientiﬁc community. SIDIAP is one of the few primary care databases
containing information on Southern European populations.
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to record prescribing and relevant patient-encounter
events in accordance with strict quality standards.
Furthermore, data are routinely validated by an ‘up-
to-standard’ audit, conﬁrming the quality of data
recording in several key areas.1 By contrast, SIDIAP
consists of all the available clinical information from
the general population. Given this situation, it is
important to develop stringent posterior validation
systems of the quality of data in order to adapt them to
the speciﬁc needs of research.
This study aims to create and validate a scoring
system, the Registry Quality Score (RQS), enabling all
primary care practices (PCPs) to be selected as pro-
viders of research-usable data based on the complete-
ness of their registers.
Methods
Study design
The study was cross-sectional and population-based.
Setting
The primary care structure in the region of Catalonia
(north-east Spain) comprises 358 PCPs composed of
health professionals and support staﬀ who are respon-
sible for the health care of the population in a given
geographical area.
The Catalan Institute of Health manages 274 PCPs;
the remainder are managed by other healthcare pro-
viders.
PCPs are constituted by three or more basic care
units (BCUs), each of which is made up of one GP and
one nurse who share a common list of patients.
SIDIAP comprises the clinical information coded in
the corresponding medical records of all PCPs, with
a total of 3414 BCUs. The global adult population
assigned to any of these BCUs is 4 859 725 (from 2005
to 2009, 80% of the total population of Catalonia).
Population
BCUs with fewer than 500 people assigned to them
were excluded from the analysis with the result that
3310 BCUswere ﬁnally included, serving a population
of 4 828 792. BCUs with fewer than 500 people
assigned to them are typically either created in re-
sponse to temporary population increases (e.g. in the
tourist season)or to speciﬁcally enableGPswhoperform
administrative tasks (e.g. PCP managers and teaching
coordinators) to have a lighter workload. The last-year
user population (those who were seen by their GP/
nurse at least once in the last year) was chosen for
setting the RQS cut-oﬀ and comprised 3 403 324
people (70%).
Figure 1 shows the criteria for the population
selection.
Figure 1 Basic care units and population of the SIDIAP database
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RQS calculations
Diseases that were likely to be representative of com-
mon diagnoses seen in primary care were selected for
RQS calculations. Both pathologies that are used as
indicators in evaluating the quality of the health care
provided by each GP and those that are not were taken
into consideration. The chronic conditions selected
were hypertension, chronic obstructive pulmonary
disease, heart failure, ischaemic heart disease, osteo-
arthritis, arthritis and hypothyroidism. Pneumonia
and cystitis were included as acute diseases. All of these
diseases were ascertained using ICD-10 codes.
The observed/expected cases ratio was calculated
for each disease. In the case of chronic conditions,
observed cases were the number of people with any of
the listed diseases up to 31 December 2009, whereas in
the case of acute conditions, the observed cases were
the number of people with either of the two diseases
newly coded at any point between 1 January 2009 and
31 December 2009. The expected value of diseases
by age and sex was deﬁned as the mean value of the
prevalence of a disease from all BCUs and was obtained
by means of indirect standardisation using the total
population as a reference and the speciﬁc rates of the
conditions by age and sex for each BCU (Box 1).
Once we had obtained an estimated value for this
ratio for each one of the selected conditions we added
up the ratios calculated for each condition in order to
obtain a ﬁnal score, which we deﬁned as the Registry
Quality Score (RQS). Every BCU is assigned with its
resulting RQS.
We compared observed and expected prevalences
(as published in the available literature) for a list of
reference conditions, diﬀerent from those included in
RQS calculations. This ratio was used to set the RQS
cut-oﬀ, which will allow us to select PCPs as providers
of research-usable data. The criteria for selecting the
pathologies were the same as those used for the RQS
calculations: long-term and acute conditions often
seen in primary care were considered as eligible. The
reference conditions ﬁnally selected were: atrial ﬁbril-
lation, diabetes, obesity, schizophrenia, stroke, uri-
nary incontinence and Crohn’s disease. Local or high-
quality and representative populationwere the criteria
for considering published prevalences in the available
literature in order to obtain a reference prevalence/
incidence of each of these conditions to which we
could compare our estimators.
Statistical analysis
Mean prevalences and their corresponding 95% con-
ﬁdence intervals by speciﬁc age and sex distributions
of the conditions of reference were calculated accord-
ing to RQS quintiles. The RQS cut-oﬀ was set as the
quintile where most of the prevalences were the same
as those described in the literature (interval esti-
mation).
For validation purposes, comparison between the
total SIDIAP population and the resulting RQS popu-
lation was then performed in terms of age, sex and the
mean prevalences of the diseases used in the RQS
calculations. Distribution of the conditions of refer-
ence by age and sex were also calculated.
In order to assess the representativeness of the RQS
population, the age and sex distribution of the popu-
lation of Catalonia (2009 census) and the resulting
RQS population were compared using a population
pyramid plot. Moreover, the participating PCPs (as
based on RQS scores for each of their GPs) were
represented spatially throughout the territory in order
to assess their representativeness.
Analyses were performed using the Statistical Pack-
age for the Social Sciences (SPSS), version 13.0, Stata
Statistical Software (Stata), release 9, and ArcView 3.2.
Box 1 Standardisation
A principal role in epidemiology is to compare the incidence or prevalence of disease or mortality between
two ormore populations. However, the comparison of crudemortality ormorbidity rates is oftenmisleading
because the populations being compared may diﬀer signiﬁcantly with respect to certain underlying
characteristics, such as age or sex, that will aﬀect the overall rate of morbidity or mortality.
Onemethod of overcoming the eﬀects of confounding variables such as age is to combine category-speciﬁc
rates into a single summary rate that has been adjusted to take into account its age structure or other
confounding factor. This is achieved by using the methods of standardisation.
There are two methods of standardisation and these are characterised by whether the standard used is a
population distribution (direct method) or a set of speciﬁc rates (indirect method). Both direct and indirect
standardisation involve the calculation of numbers of expected events (e.g. prevalence), which are compared
with the number of observed events.
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Results
RQS cut-oﬀ
Table 1 shows themeanprevalence of the diseases used
in rate comparisons in accordance with the RQS score
quintiles. In relation to interval estimation, atrial
ﬁbrillation and diabetes prevalence were the same
as the literature from the ﬁrst quintile, whereas the
reference for obesity, schizophrenia and stroke corre-
sponded with the second quintile. Urinary inconti-
nence reached the reference interval from the fourth
quintile and only Crohn’s disease always showed a
lower prevalence rate than the reference. Hence, apart
from Crohn’s disease, all prevalences are the same as
the reference from the fourth quintile (60th percen-
tile) onwards. This RQS cut-oﬀ provides a total popu-
lation available of 1 936 443 (39.6% of the total
SIDIAP population).
RQS validation
RQS general characteristics
Table 2 shows that theRQSpopulation is similar to the
SIDIAP population with respect to age and sex distri-
bution. However, the mean prevalence of the diseases
used for the RQS scoring are, as expected, slightly
higher in the RQS population.
Prevalences for conditions used to
validate RQS by age and sex
As seen in Figure 2, prevalence rates increase gradually
with age for atrial ﬁbrillation, stroke and diabetes in
both sexes, although these prevalences are somewhat
greater in men than in women. Urinary incontinence
also increases with age but remains more prevalent in
women. With regards to obesity, a steep rise is observed
from about 30 years of age in both sexes, although this
is more marked in women, and a peak is reached
between 50 and 70 years. Finally, schizophrenia and
Crohn’s disease appear to be more prevalent at younger
ages. Schizophrenia is more frequent in men, whereas
no diﬀerences in prevalence between sexes are observed
in the case of Crohn’s disease.
RQS population structure and
geographical representativeness
Figure 3a shows the comparison between the RQS
age–sex population and the population of Catalonia
(census of 2009) and Figure 3b shows the geographical
distribution of the existing 274 PCPs in Catalonia.
Table 1 Rate comparison. RQS cut-oﬀ (1-year user population; n = 3 403 324)
Conditions of reference (age range)
AF
(> 40
years)
Diabetes
(35–74
years)
Obesity
(25–60 years)
Schizo-
phrenia
(15–54
years)
Stroke
(35–79
years)
UI
(women >
65 years)
Crohn’s
disease
(all ages)
RQS quintiles
First 2.37
(2.32–2.41)
7. 67
(7.59–7.75)
8.57
(8.48–8.67)
0.68
(0.65–0.70)
1.72
(1.68–1.76)
6.66
(6.50–6.82)
0.10
(0.09–0.11)
Second 2.82
(2.77–2.87)
8.21
(8.13–8.29)
10.52
(10.42–10.61)
0.74
(0.72–0.77)
1.99
(1.95–2.03)
8.90
(8.70–9.11)
0.11
(0.10–0.12)
Third 2.85
(2.80–2.89)
8.49
(8.41–8.57)
11.14
(11.04–11.24)
0.76
(0.74–0.79)
2.09
(2.04–2.13)
9.21
(9.03–9.39)
0.11
(0.11–0.12)
Fourth 2.92
(2.87–2.97)
8.66
(8.58–8.74)
11.87
(11.77–11.97)
0.77
(0.75–0.80)
2.15
(2.11–2.19)
9.93
(9.74–10.12)
0.12
(0.12–0.13)
Fifth 3.00
(2.96–3.05)
9.24
(9.16–9.32)
13.53
(13.42–13.63)
0.85
(0.82–0.88)
2.28
(2.24–2.33)
11.47
(11.27–11.68)
0.13
(0.12–0.14)
Reference
ratesb
2.52
(1.58–4.01)
7.0
(6.7–7.4)
11.2 (10.10–
12.3)
0.80
(0.73–0.88)
2.24
(1.90–2.63)
10–20a 0.18
(0.15–0.21)
Notes: AF, atrial ﬁbrillation; UI, urinary incontinence. a Range. b See refs 12–18.
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PCPs frommost of the territory have been included in
the RQS. Black dots represents PCPswhere at least one
BCU is included in the RQS and white dots represent
PCPs without any BCU in the RQS.
Discussion
Summary of the main ﬁndings
SIDIAP comprises most of the clinical information
recorded by primary care health professionals (GPs
and nurses) and administrative staﬀ in electronic
medical records. The database contains this infor-
mation for almost ﬁve million people, representing
approximately 80% of the total population aged over
15 years old in the region of Catalonia (north-east
Spain).
We report here the methods used to create and
validate a scoring system (RQS) that can be used to
choose BCUs with a good quality of coding, as deﬁned
by the completeness of the registers. As shown, 40% of
the participating professionals with the highest RQS
score achieve, for all of the long-term and acute
conditions explored except Crohn’s disease, preva-
lence and incidence rates that are comparable with
those published in the available literature. Hence, we
propose to use the 60th RQS percentile as a suitable
cut-oﬀ to establish what can be deﬁned as research-
usable information. Using this cut-oﬀ, we can provide
reliable clinical data on about twomillion people, and
on a total of almost ten million person-years for the
period 2005–2009.
The RQS score for each BCU will be updated on a
six-monthly basis, and data corresponding to the up-
to-date RQS will be used to decide which participants
will be excluded.
Comparison with existing literature
Rate comparison is a widely used method for the
validation of several variables in primary care data-
bases and has been used inmany publications to explore
the completeness of the information contained in
well-known databases such as the GPRD7,8. Rate
comparison has also been used as a method to assess
the quality of coding of some particular conditions in
the same database (e.g. chickenpox, hay fever, asthma
and diabetes9) and to validate similar sources of
information for monitoring certain prescriptions.10
Table 2 Sociodemographic characteristics and RQS internal prevalences. Comparison
between SIDIAP population and RQS population
SIDIAP (n = 4 828 792) RQS population (n = 1 936 443)
Mean age years (SD) 46.19 (18.73) 45.59 (18.85)
Women 50.70 (50.65–50.74) 50.71 (50.64–50.78)
Hypertension 17.74 (17.70–17.77) 18.75 (18.70–18.81)
COPD 2.32 (2.30–2.33) 8.40 (8.34–8.45)
> 65 years 2.70 (2.68–2.72) 10.56 (10.45–10.66)
Ischaemic heart disease 2.26 (2.25–2.27) 2.45 (2.43–2–47)
Heart failure 0.90 (0.90–0.91) 4.13 4.09–4.17)
> 65 years 1.09 (1.08–1.11) 5.70 (5.62–5.78)
Rheumatoid arthritis 0.37 (0.37–0.38) 0.45 (0.44–0.46)
Hypothyroidism 1.67 (1.66–1.68) 1.99 (1.97–2.01)
Cystitis 0.67 (0.67–0.68) 1.09 (1.08–1.10)
Pneumonia 0.32 (0.32–0.33) 0.44 (0.43–0.45)
Osteoarthritis 0.68 (0.67–0.69) 2.18 (2.15–2.21)
> 65 years 0.89 (0.87–0.90) 3.17 (3.11–3.23)
Notes: Values are given as percentages and 95% CI unless otherwise stated. COPD, chronic obstructive pulmonary disease.
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However, we propose the use of a newly created
score – RQS – based on rate comparison to decide on
the usefulness of data for research purposes.
Alternative methods using parameters such as checks
in the continuity of data; relative rates of recording for
various events including referrals, prescribing and
immunisations; logical recording practices such as the
recording of indications with acute prescribing and
appropriate recording of registration details; and checks
on mortality rates as a proxy for mass deletions of old
patients, have all been used to select research-usable
data in similar primary care databases, such as theDIN
database,5 and the GPRD.1 However, none of these
methods has proven to provide better data quality
than the others.
In the particular case of our database, previous
studies11 have shown that the main problem with
the data is lack of completeness due to the under-
recording of certain conditions and thus our proposed
method was considered, a priori, to be a useful tool in
identifying health professionals with a good quality of
coding and research-usable data. Furthermore, these
methods are consistent with the nature of our data-
base, which does not consist of information sent by
volunteer participants (like GPRD or QResearch) but
of the whole set of PCPs in the Institut Catala` de la
Salut (Catalan health service). By using the rate com-
parison method with the RQS score, permitting the
identiﬁcation of research-usable data, allowance is
made for the fact that GPs entering data as part of
their standard clinical practice may not have the same
level of awareness and motivation as volunteer partici-
pants. Further validation studiesmay show thesemethods
to be generalisable to other similar databases.
As is seen in the results, our ﬁndings show that the
RQS, which is based on the prevalence/incidence rates
of nine speciﬁc conditions, correlates well with the
reference rates for atrial ﬁbrillation,12 diabetes,13 obesity,14
schizophrenia,15 stroke16 and urinary incontinence.17
In the case of Crohn’s disease,18 the ﬁnding of a lower
prevalence than expectedmay be explained by the fact
that most of the prevalence studies reviewed used
screening methods that are not applicable to a general
population attending primary care.
We have also shown that when age- and sex-speciﬁc
prevalences are considered in the RQS population, all
of the studied conditions ﬁt with their known epi-
demiological pattern.12–18 This gives further support
to the good degree of accuracy of the coding in this
population.
Figure 2 RQS reference prevalences by age and sex
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Implications of the ﬁndings
Several databases that are similar to SIDIAP in terms
of the information collected, data sources and primary
care clinical setting are currently being used for
cohort, case–control and other study designs. How-
ever, most of these databases contain information
based on Northern European or North American
populations, whereas SIDIAP provides similar clinical
variables for Southern Europe. It is this diﬀerential
characteristic that makes our data particularly inter-
esting. With the addition of this database it will be
possible to compare the epidemiology of numerous
conditions in Southern and Northern European
populations.
The fact that these databases can provide large
sample sizes at a comparatively low cost and that
they permit long follow-up periods without directly
requiring the participation of the subjects, whilst min-
imising biases such as the Healthy Worker and the
Hawthorne eﬀects, has made them especially inter-
esting for public health research. Good examples of
applications of database-based studies are the recently
published predictive tools made available to clinicians
to help estimate the absolute risk of fragility fractures
(QFracture)19 and of cardiovascular events (QRisk),20,21
which have been modelled using QResearch Database
data.22
Limitations
Although rate comparison is a very good approach to
ascertain the completeness of electronic records, the
main limitation of this study is that we cannot provide
an external source of information to allow individual-
ised comparison of the information recorded in our
data, because the reference prevalence rates found in
the literature may not be correct. Accurate case deﬁ-
nition is essential for the reliable reporting of the
prevalence of a condition23 and, as a result, the accuracy
of coding cannot be guaranteed at an individual level.
However, the fact that the descriptive epidemiology
overlaps the known patterns for each of the conditions
studied supports the validity of the data. A variety of
gold standards have been used, and completeness and
validity can only be inferred in relation to the quality
of the gold standard used (paper information practice,
questionnaires sent to GPs, linkage to external registers,
Figure 2 continued
Selection of high-quality data in a primary care database 143
Figure 3(a) and (b) Age-sex population structure and geographical representativeness
(a)
(b)
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hospital discharge databases, reliable cohort studies).24
Techniques like data quality probes to develop internal
diagnostic algorithms to identify cases could avoid the
problem of the misclassiﬁcation of diagnostic codes
and provide a valuable method for monitoring data
accuracy.25,26 Moreover, procedures such as partici-
pating feedback and audits have shown their useful-
ness in improving data quality.27 Besides, control
charts and cumulative-sum charts can be a good
approach formonitoring the cumulative performance
of recorded medical information over time.28
In addition, numerous SIDIAP-based projects aim
to validate certain conditions using external databases
(hospital discharge database, mortality register, etc.)
in a similar way as to validations that have been made
using the GPRD.29,30
The under-recording we have observed in SIDIAP
has also been found to be a common weakness in
similar databases. This could lead to a random mis-
classiﬁcation error, and therefore to a reduction in
statistical power.
Conclusions
SIDIAP contains information on the majority of the
population of Catalonia, and is highly representative
of the whole region in terms of geographical, age and
sex distributions. As we have previously described,
more than two thirds of the population of Spain see
their GP at least once a year.31
Because the information contained in SIDIAP is
collected by health professionals during routine visits,
it provides a good source of population-based data
and reliably reproduces the actual conditions of clini-
cal practice in our setting.
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